AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 175 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $800,000 | -17.9% | 40,000 | -20.0% | 0.28% | +63.8% |
| Q2 2018 | $975,000 | -3.3% | 50,000 | 0.0% | 0.17% | +5.5% |
| Q1 2018 | $1,008,000 | -42.6% | 50,000 | -62.3% | 0.16% | -50.3% |
| Q4 2017 | $1,756,000 | +90.2% | 132,500 | +165.0% | 0.33% | +101.2% |
| Q3 2017 | $923,000 | -18.6% | 50,000 | +88.0% | 0.16% | -78.5% |
| Q4 2014 | $1,134,000 | – | 26,596 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,650,000 | $48,893,000 | 3.10% |
| Voce Capital Management LLC | 110,789 | $2,044,000 | 2.72% |
| Palo Alto Investors LP | 3,441,233 | $63,491,000 | 2.67% |
| FALCON POINT CAPITAL, LLC | 839,477 | $13,180,000 | 1.91% |
| EII CAPITAL MANAGEMENT, INC. | 119,690 | $2,208,000 | 0.83% |
| CLARK ESTATES INC/NY | 163,300 | $3,013,000 | 0.50% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 38,358 | $708,000 | 0.50% |
| Jabre Capital Partners S.A. | 120,000 | $2,214,000 | 0.43% |
| Credit Capital Investments LLC | 15,000 | $277,000 | 0.31% |
| Alambic Investment Management, L.P. | 151,442 | $2,794,000 | 0.30% |